Archives
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
Wnt Agonist 1 (BML-284): Precision Tools for Wnt Pathway Res
2026-07-15
Explore how Wnt agonist 1 enables quantitative control of canonical Wnt signaling, advancing research in cellular differentiation and chemoresistance. This article delivers a unique, protocol-focused analysis anchored by recent mechanistic breakthroughs.
-
Sodium Oxamate: Precision Inhibition for Cancer Metabolism S
2026-07-15
Sodium Oxamate (Oxamic Acid) delivers targeted, reproducible inhibition of LDH-A, enabling advanced analysis of glycolytic reprogramming in cancer and viral infection models. This guide details applied protocols, troubleshooting, and cross-domain insights for confident deployment in metabolic research.
-
Hepatic sEH Suppresses Nrf2 to Drive Osteoclastogenesis in O
2026-07-14
A recent study reveals that hepatic soluble epoxide hydrolase (sEH) aggravates osteoporosis by suppressing the Nrf2 antioxidant pathway, thereby promoting osteoclast differentiation. This mechanistic insight into the liver-bone axis underscores new targets for redox and signaling pathway modulation in bone disease.
-
PPT (Propyl Pyrazole Triol): Driving Precision in ERα Functi
2026-07-14
Explore how PPT (Propyl Pyrazole Triol) empowers unparalleled specificity in estrogen receptor alpha research. This article uniquely dissects quantitative assay decision-making and ceRNA network implications, offering researchers actionable insights beyond standard protocols.
-
MAPK-SNARE13 Crosstalk in BABA-Induced Peach Fruit Immunity
2026-07-13
This study reveals how β-aminobutyric acid (BABA) enhances resistance in postharvest peach fruit by activating a MAPK cascade that interacts with SNARE13 protein within a salicylic acid-dependent pathway. The work provides mechanistic insight into plant immune priming and offers a molecular framework for protein phosphorylation analysis in signaling research.
-
Anlotinib Hydrochloride: Multi-Kinase Inhibition of Tumor An
2026-07-13
This study demonstrates that anlotinib hydrochloride is a potent multi-target tyrosine kinase inhibitor that suppresses angiogenesis by inhibiting VEGFR2, PDGFRβ, and FGFR1 signaling pathways in vitro and in vivo. The findings highlight its superior efficacy over established anti-angiogenic agents, offering valuable mechanistic insights for researchers in cancer biology and vascular studies.
-
HLY78: Precision Wnt/β-catenin Pathway Modulator in Research
2026-07-12
HLY78 uniquely empowers researchers to activate the Wnt/β-catenin pathway with high specificity, enabling robust modeling of embryogenesis, stem cell induction, and fibrosis. Its Axin-targeted mechanism delivers practical advantages for dissecting pathway dynamics and developing advanced disease models.
-
CH 223191: Advanced Applications for AhR Antagonism in Toxic
2026-07-10
Explore the unique role of CH 223191 as a potent aryl hydrocarbon receptor antagonist in environmental toxicology and mechanistic gut research. This in-depth guide reveals how CH 223191 enables precise modulation of the AhR signaling pathway, advancing dioxin toxicity mechanism studies and intestinal stem cell research.
-
T0070907: Precision PPARγ Antagonism for Translational Impac
2026-07-09
This thought-leadership article explores the transformative role of T0070907 as a next-generation PPARγ antagonist, highlighting its mechanistic underpinnings, translational potential in adipogenesis and inflammation, and strategic guidance for advanced experimental design. Drawing on recent discoveries around the RXRα/PPARγ/NEDD4 axis and referencing pivotal research, the article connects foundational biology to practical protocols and future directions, offering translational researchers a pathway to leverage T0070907 for disease modeling and therapeutic exploration.
-
Agatoxin-IVA-Sensitive Calcium Channels in Cardiac Vagal Neu
2026-07-09
This study delineates the essential role of agatoxin-IVA-sensitive (P-type) voltage-dependent calcium channels in both presynaptic and postsynaptic nicotinic activation of cardiac vagal neurons. The findings clarify the molecular mechanisms underlying neurotransmission and offer new perspectives for dissecting calcium signaling in neurocardiac regulation.
-
Silymarin: Milk Thistle Extract in Advanced Oxidative Stress
2026-07-08
Silymarin, a milk thistle extract, stands out as a robust reference compound for mechanistic studies in oxidative stress, cancer, and antiviral research. This guide translates recent advances in silybin chemistry into stepwise protocols, troubleshooting strategies, and domain-bridging applications that empower reproducible, high-impact results.
-
RNA Pol II Loss Triggers Apoptosis Beyond Transcriptional Sh
2026-07-08
Harper et al. (2025) reveal that cell death from RNA Pol II inhibition is not due to simple loss of transcription, but is instead driven by an active, regulated apoptotic response to the degradation of hypophosphorylated RNA Pol IIA. These findings reshape our understanding of the DNA damage response, with broad implications for targeting transcriptional machinery in cancer biology research.
-
T0070907: Precision PPARγ Antagonist for Pathway Dissection
2026-07-07
T0070907 enables high-fidelity modulation of PPARγ signaling in both metabolic and cancer models, delivering sub-nanomolar potency and selectivity. This guide translates recent mechanistic insights and validated protocols into actionable workflows for researchers needing robust PPARγ pathway inhibition.
-
Octanoic Acid Nutrition Modulates IBD via PPARγ/STAT Pathway
2026-07-07
This study demonstrates that octanoic acid-rich enteral nutrition alleviates inflammatory bowel disease (IBD) by regulating intestinal macrophage polarization through the PPARγ/STAT-1/STAT-6 signaling axis. The findings reveal a mechanistic link between dietary components and immune modulation, offering new avenues for nutritional intervention strategies in IBD.
-
740 Y-P: Protocol-Driven PI 3-Kinase Activator for Cell Rese
2026-07-06
740 Y-P is a potent, cell-permeable PI 3-kinase activator designed for precise modulation of the PI3K/AKT pathway in vesicular trafficking, neuronal survival, and apoptosis research. Researchers should use it where reliable, reversible PI3K activation is required, but avoid applications outside well-validated cell-based or biochemical contexts due to limited cross-domain evidence.